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Abstract
Background: Following a nuclear incident, the communication and perception of radiation risk
becomes a (perhaps the) major public health issue. In response to such incidents it is therefore
crucial to communicate radiation health risks in the context of other more common environmental
and lifestyle risk factors. This study compares the risk of mortality from past radiation exposures
(to people who survived the Hiroshima and Nagasaki atomic bombs and those exposed after the
Chernobyl accident) with risks arising from air pollution, obesity and passive and active smoking.
Methods: A comparative assessment of mortality risks from ionising radiation was carried out by
estimating radiation risks for realistic exposure scenarios and assessing those risks in comparison
with risks from air pollution, obesity and passive and active smoking.
Results: The mortality risk to populations exposed to radiation from the Chernobyl accident may
be no higher than that for other more common risk factors such as air pollution or passive smoking.
Radiation exposures experienced by the most exposed group of survivors of Hiroshima and
Nagasaki led to an average loss of life expectancy significantly lower than that caused by severe
obesity or active smoking.
Conclusion: Population-averaged risks from exposures following major radiation incidents are
clearly significant, but may be no greater than those from other much more common
environmental and lifestyle factors. This comparative analysis, whilst highlighting inevitable
uncertainties in risk quantification and comparison, helps place the potential consequences of
radiation exposures in the context of other public health risks.
Background
Uncontrolled releases of radioactive material to the envi-
ronment have major public health consequences over and
above the direct health impacts of the radiation. For exam-
ple, the economic, social and health impacts of the 1986
Chernobyl accident have been shown to have been greatly
exacerbated by people's understandable fear of radiation
[1,2]. The primary way of communicating unfamiliar risks
to the public is by comparison with other more common
risk factors. The present work carries out a novel assess-
ment of radiation risk by evaluating scenarios for mortal-
ity risks from radiation and comparing these risks with
risks from air pollution [3], obesity [4] and passive [5] and
active [6] smoking.
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It is always important to highlight the limitations of
assessments of public health risk factors. The risk esti-
mates presented here represent population-averaged
increased mortality risks which cannot necessarily be
interpreted as risks to the individual. Despite advances in
the epidemiology of many health risk factors, direct quan-
tification of different risks is still subject to significant
uncertainty. For example, the timing and nature of a
health detriment following a radiation exposure is likely
to be different to that following exposure to air pollution.
A recent study of health detriments from mercury in fish
[7] has presented a risk-benefit analysis based on a "qual-
ity adjusted life years" approach which attempts to
account for different timings and types of health detri-
ment. Such an analysis is, however, beyond the scope of
this paper as significant uncertainties remain in morbidity
endpoints in some of the risk factors studied.
It is further noted that quantitative risk comparison is
only one of many factors determining attitudes to risk [8]
and that such comparisons cannot address some impor-
tant ethical issues concerning, for example, differences
between an imposed risk (radiation exposure in an
extreme event) and a (to a certain extent) voluntary risk
such as active smoking. A discussion of ethical issues
related to radiation risk can be found in, for example,
Oughton [9].
Extremely high doses of radiation lead rapidly to acute
health effects (Acute Radiation Syndrome or ARS) which
can be fatal. Many of the approximately 210,000 people
who died in the immediate aftermath of Hiroshima and
Nagasaki were victims of ARS and, following Chernobyl,
134 plant operators and emergency workers were diag-
nosed with ARS, 40 of whom died [10]. Lower, more pro-
longed, exposures to radiation do not necessarily lead to
adverse health effects, but they can lead to an increased
probability of a health detriment in later life. Because of
their random nature, these effects are termed "stochastic"
effects. Most importantly, following radiation exposure
there is a certain probability that the individual will con-
tract cancer in later life, though in most cases the exposure
will have no effect. This paper focuses on cancer mortality
risk and loss of life expectancy from ionising radiation
and does not aim to give a full review of the health conse-
quences of the Chernobyl accident and the Hiroshima
and Nagasaki atomic bombs. Health consequences of
Chernobyl (including, for example, ARS and thyroid can-
cer) have been reviewed elsewhere (e.g. [2,10-12]).
The scope of this paper is therefore to quantify different
risks with their attendant uncertainties and differing
health endpoints, with the focus here on mortality. The
complex task of interpreting these risks and making (often
subjective) value judgements on risk acceptability and risk
comparison is beyond the scope of this paper.
Methods
Developing radiation risk scenarios
Using epidemiological studies, primarily (but not only) of
survivors of the Hiroshima and Nagasaki atomic bombs
(Figure 1; [13]), radiation protection agencies have esti-
mated the lifetime cancer risk to people from exposure to
ionizing radiation [14,15]. Risk estimates recommended
by the International Commission on Radiological Protec-
tion [15] are used to calculate stochastic radiation risks.
These estimates predict a fatal cancer risk of 0.05 per siev-
ert (Sv) of effective dose to the general population and
0.04 per Sv to the working population (the different pop-
ulation age distribution accounts for the difference in
risk). The ICRP risk estimate implies, for example, that if
a population is exposed to low dose rate radiation leading
to an average effective dose equivalent of 0.1 Sv (100
mSv) to each person, an additional 0.5% of people will
suffer a fatal cancer. Typically, the "natural" cancer inci-
dence in industrialised countries is 20–25%. The radia-
tion-induced cancers would not occur immediately, but
may arise many years after exposure. Note that risks aver-
aged over a population are presented here: the distribu-
tion of risks within a population will vary according to
factors such as age and sex.
The ICRP risk estimate [15] assumes a dose and dose-rate
effectiveness factor (DDREF) of 2.0 (reducing predicted
risk by a factor of 2.0) for extrapolation of the data from
the bomb survivors (who were exposed at extremely high
dose rate) to lower dose and/or dose-rate exposures. "Low
dose" has been defined as < 100 mSv [14], though there is
no precise definition. Some assessments of cancer mortal-
ity following Chernobyl (e.g. [11]) did not apply a
DDREF, whilst others did (e.g. [16]). The present study
uses the ICRP risk estimates which include a DDREF, but
where appropriate it is noted that risk predictions would
be increased by a factor of 2 should the DDREF be
excluded.
In calculating radiation risks, the ICRP approach [15] has
been used for consistency. Separate risk factors were
applied for exposures to the average population and for
occupational exposures to the population of working age.
The US National Academy of Sciences has also recently re-
assessed risks from low dose, low linear energy transfer
radiation [14], in particular updating uncertainty esti-
mates in risk. These new risk estimates were compared
with the previous ICRP [15] estimates and no substantial
differences were found for the cases studied here. It is fur-
ther noted that the US National Academy of Sciences [17]
and US Environmental Protection Agency [18] have
recently re-assessed the lung cancer risk from exposures toBMC Public Health 2007, 7:49 http://www.biomedcentral.com/1471-2458/7/49
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Illustration of cancer mortality risk from ionizing radiation Figure 1
Illustration of cancer mortality risk from ionizing radiation. Fatal (a) solid cancer; (b) leukaemia rates (1950–2000) in 
people exposed to radiation from the Hiroshima and Nagasaki atomic bombs using data presented in ref. [13]. Mortality rates 
are per 10,000 people. In the 86,611 member cohort, of the 6061 cancer deaths observed in all persons exposed to more than 
0.005 Sv, approximately 578 were attributed to radiation exposure.
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radon in the home. This risk estimate is discussed further
below.
For the inter-comparison of radiation risks, scenarios were
chosen in order to illustrate a range of different exposures
from a few mSv up to several hundred mSv. For the com-
parison of radiation risks with other environmental risk
factors, doses to approximately 200,000 Chernobyl emer-
gency workers ("liquidators") were used as an illustration
of relatively high exposures after a radiation incident. As
exposures to passive smoking and air pollution represent
averages for the exposed group it is appropriate to com-
pare these with average exposures to the Chernobyl emer-
gency workers (100 mSv). But exposures to the high dose
group (250 mSv) of Chernobyl emergency workers are
also presented for comparison. For comparison of radia-
tion risks with active smoking and obesity, loss of life
expectancy of atomic-bomb survivors in the high dose
group (2.25 Gy) is used. Lower exposures led to a signifi-
cantly lower loss of life expectancy: for example, those
exposed to < 1 Gy (mean 140 mGy) had a life expectancy
which was on average 70 days shorter than that of zero-
dose individuals [19].
Radiation exposures were estimated for each of the illus-
trative radiation risk scenarios. The percentage mortality
from low dose/dose rate radiation was calculated using:
% mortality risk = 100.HE.Rc
where HE (in Sv) is the effective dose, and Rc (in Sv-1) is the
ICRP [15] risk coefficient for either the general or work-
ing-age populations.
For long term exposures from the Chernobyl accident
(primarily from 137Cs), an effective ecological half life of
25 years was conservatively assumed [20] to model the
change in exposure over time. For example, in the sce-
nario illustrating consumption of sheep meat in the UK,
doses to "critical group" consumers were estimated for a
"worst case" scenario of exposure to an infant born in
1986 consuming lamb from affected farms for his or her
75 year lifetime. Critical group intake rates and effective
doses per unit intake were taken from [21]. It was
assumed that lamb was contaminated with 500 Bq kg-1 in
1986 declining with effective ecological half life 25 years
[20]. This is an over-estimate of likely real exposures.
Risks from air pollution
A recent cohort study of approximately 500 000 adults in
US cities [3] showed that "each 10 μg m-3 elevation in fine
particulate [PM2.5, particles less than 2.5 μm diameter] air
pollution was associated with approximately a 4%, 6%,
and 8% increased risk of all-cause, cardiopulmonary, and
lung cancer mortality, respectively". The relative risk (RR)
of all cause mortality was 1.04 with CI 1.01–1.08. It is
assumed that the epidemiological findings of Pope et al.
[3] indeed represent causal relationships between ambi-
ent air pollution (as measured by PM2.5) and mortality.
In 2005, the mean annual PM10 concentration in London
was approximately 28.5 μg m-3 (mean of 8 sites) com-
pared to 17 μg m-3 in Inverness [22], the least polluted of
the UK cities monitored by DEFRA. Using a ratio
PM10:PM2.5 = 1.67 applied to US data [23] (c.f. a study in
Birmingham (UK) [24] which gave a ratio of means of
1.61) this gives estimated PM2.5 of 17.1 μg m-3 and 10.2 μg
m-3 in London and Inverness respectively. (Note also that
a study reported in [23] measured a mean value of 18 μg
m-3 PM2.5 at 3 urban background sites in London in 2000–
2001). If the Pope et al. [3] finding of 4% increased mor-
tality risk per 10 μg m-3 increase in PM2.5 is applicable to
the UK, this difference represents a predicted 2.8%
increase in mortality in Central London (compared to
Inverness) as a result of air pollution.
Risks from obesity
It is well known that increased body fat can lead to
increased risk of mortality. An individual's body fat is usu-
ally defined by their body-mass index (BMI, kg/m2). It is
now well known that high BMI potentially poses major
health risks to a significant proportion of people in devel-
oped countries. For example, 127 million Americans are
classed as overweight (25.0 ≤ BMI ≤ 29.9), 60 million are
classed as obese (30.0 ≤ BMI ≤ 39.9) and 9 million are
classed as severely obese (BMI ≥ 40) [25].
A study of more than 1 million US adults [4] analysed the
relationship between BMI and mortality in a 300,000 per-
son sub-group of non-smokers. The study adjusted for
other potential risk factors such as level of education and
physical activity. Whilst noting some remaining uncer-
tainties [4], the study of this sub-group showed a clear
relationship between BMI and all-cause mortality, and
mortality from both cardiovascular disease and cancer
(Figure 2). Fontaine and coworkers [26] used data from
the U.S. National Health and Nutrition Examination Sur-
veys to determine years of life lost (YOLL) due to over-
weight and obesity in comparison with a reference BMI of
24.
Note that a recent study [27] observed only increased
mortality (relative to a 18.5 < BMI < 25.0 control group)
in groups with BMI > 30.0 and decreased relative mortal-
ity in a group with BMI between 25 and 29.9 (over-
weight). This has caused controversy over the BMI-
mortality relationship: the Flegal et al. [27] study contra-
dicts earlier studies, but has been criticised by other work-
ers in the field (for both sides of this discussion, see
[28,29]).BMC Public Health 2007, 7:49 http://www.biomedcentral.com/1471-2458/7/49
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Risks from smoking and passive smoking
About half of all smokers suffer an early death from a
smoking-related disease [6]. The relationship between
smoking and a number of different cancers [30] and car-
diovascular diseases [31] is of course well established. For
example, in a 50-year study of health effects of smoking in
male British doctors [6], it was shown that a 35 year old
male doctor who smoked had a life expectancy approxi-
mately 10 years lower than for those doctors who had
never smoked (Figure 3).
Because of the much lower relative risks involved, levels of
adverse health effects from passive smoking are less cer-
tain than those from active smoking. Studies have, how-
ever, shown correlations between passive smoking and a
number of diseases including lung cancer and heart dis-
ease. A meta-analysis of 37 epidemiological studies of
lung cancer [32] found a relative risk (RR) of lung cancer
of 1.24 (CI: 1.13–1.36) in non smokers who lived with a
smoker compared to non-smokers whose partner did not
smoke. A meta-analysis of 19 published studies [33]
observed a relative risk of heart disease of 1.23 (CI: 1.14–
1.33) in non-smokers who lived with a smoker compared
to non-smokers whose partner did not smoke. A number
of other potentially fatal conditions have also been linked
to passive smoking [34].
It has been estimated that in the U.S., passive smoking
annually accounts for 60,460 excess deaths comprised of
47,000 deaths from heart disease, 3,060 deaths from lung
cancer and 10,400 from other cancers [35]. A study [36] of
ischaemic heart disease (IHD) estimated an excess mortal-
ity risk for a non-smoker living with a spouse who smokes
of 2.2% for men and 1.2% for women (assumed RR for
heart disease: 1.31 and 1.24 respectively).
Results and discussion
Exposure and risk scenarios
Different radiation risks can be directly compared to each
other since there is a common link between exposure and
risk. Such risk comparisons are based on the LNT model,
combined with internal and external exposure models
and estimates of the biological effectiveness of different
radiation types. Table 1 summarises different exposures
and risks from natural and medical radiation sources and
compares these with illustrative exposures following the
Chernobyl accident. Doses are expressed as risk for the
total exposure over the specified time period. Note that
exposures from Chernobyl do not here include dose to the
thyroid or the 134 cases of ARS resulting from exposures
during the accident (for a summary of the health effects of
Chernobyl, including thyroid cancer, see [2,10-12]).
It is clear from Table 1 that current exposures from the
Chernobyl accident are not greater (and are in some cases
much smaller) than some exposures to natural back-
ground radiation (e.g. long-haul air crew or some resi-
dents of relatively high natural background areas). Doses
to the population of approximately 200,000 emergency
workers who worked in the Chernobyl 30-km exclusion
zone in 1986–87 averaged approximately 100 mSv and
Illustration of mortality risk from active smoking Figure 3
Illustration of mortality risk from active smoking. 
Predicted survival curve from age 35 for smoking and non-
smoking male doctors (reproduced from data presented in 
[6] with permission from the BMJ Publishing Group). Per-
centage of original population surviving is shown at each dec-
ade.
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doses to residents of the "strict control zones" were on
average lower, but of the same order [37]. A group of peo-
ple living unofficially in the 30-km exclusion zone around
Chernobyl were found to receive annual doses of 1–6 mSv
yr-1 in the late 1990s [2]. A lifetime's exposure to high nat-
ural background radiation in some parts of the world can
result in an accumulated dose of 700 mSv or more (Table
1). More than 100,000 people in Finland, for example,
receive natural radiation doses > 10 mSv yr-1 [10].
Mortality risks from example exposure scenarios for air
pollution, passive smoking and radiation are shown in
Table 2. Comparing risks between different risk factors is
more uncertain than comparisons between different radi-
ation sources. The time delay in the health impact follow-
ing exposure to passive smoking or air pollution, for
example, may be different to that following exposure to
low-dose radiation.
There are significant uncertainties in risks in all the cases
shown in Table 2, however, this comparison of time- and
population-averaged risks can help to put radiation risks
in context. The radiation exposures to emergency workers
and to the most exposed populations following Cherno-
byl represented a potentially significant increase in fatal
cancers in the exposed populations. But, the risk (from the
Table 1: Illustrative radiation exposures from natural background, medical, routine nuclear operations and Chernobyl with 
hypothetical lifetime risks.
Exposure scenario Exposure Mortality risk+ Notes
Examples of radiation exposures not due to Chernobyl
General population (background exposures)
UK average (natural + medical) 200 mSv 1 % Lifetime (~75 yr) exposure to 2.7 mSv yr-1 UK average annual dose.
Exposure at UK limit for radon 
exposures in the home [49]
750 mSv 3.7 % Lifetime (~75 yr) exposure to UK limit 200 Bq m-3 radon gas ≈ 10 mSv yr-1 
dose. Above this limit, action must be taken to reduce radon in houses in the 
UK. Dose depends on time spent at home and doses at this high rate are 
rare.
Working population (above background)*
UK average for classified radiation 
workers [50]
18 mSv 0.07% Average current dose (above background) of classified workers in the 
nuclear industry of 0.6 mSv yr-1 accumulated over a 30 year working period.
Long haul air crew [51] 135 mSv 0.54% Typical exposures in the range 3–6 mSv yr-1: assume 4.5 mSv yr-1 over 30 yrs
Exposures after Chernobyl (above background)*
General population
Residents of "strict control zones" 
(areas > 555 kBq m-2 137Cs).
50 mSv 0.25% Accumulated dose for approximately 10 year period after the accident [37, 
52]
Annual dose limit to populations of 
the Chernobyl affected areas, 
1990's
75 mSv 0.37% If external + internal dose exceeded this limit, measures had to be taken to 
reduce dose. Accumulated dose at 1 mSv yr-1 over 75 yr lifetime [53]
Consumer of sheep meat from the 
most contaminated areas in the 
UK
4.1 mSv 0.02% Consumption (at a high rate) of lamb from farms most affected by Chernobyl 
for 75 year period (assumed mean 137Cs = 500 Bq kg-1 in 1986, declining with 
effective half life 25 yr). Over-estimate of likely real exposures.
Working population
Unofficial residents of the 30-km 
exclusion zone. In late 1990's 
range of doses in a number of 
villages [2], Ukrainian sector 30 km 
zone was 1–6 mSv y-1
255 mSv 1.0% Illustrative of higher exposures: person of working age (25) who received 100 
mSv during period to 1995, then returned to Zone in 1996 and received 6 
mSv yr-1 in 1996 declining (with effective half life 25 years) to age 75 in 2036. 
N.B. some (uninhabited) areas of the Zone would give much higher doses.
Chernobyl emergency workers 
[37]:
Average
High dose group
100 mSv
250 mSv
0.4%
1.0%
Accumulated risk from exposures during 1986–87. Does not include very 
high exposures to those who suffered from ARS. Working population.
+ A DDREF of 2 is applied for these (relative to the Japanese bomb survivors) low dose rate exposures. If the DDREF were not used all the risk 
factors would increase by a factor of 2. * These exposures are in addition to those from background radiation. Note that exposures to the 134 ARS 
victims and doses to the thyroid following Chernobyl are not included here (see text).BMC Public Health 2007, 7:49 http://www.biomedcentral.com/1471-2458/7/49
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evidence analysed here) appears to be no greater than
potential mortality risks from air pollution, passive smok-
ing, or high natural background radiation exposures.
Table 3 compares risks from acute, high dose radiation
with active smoking and high BMI, in terms of expected
average reduction in lifespan. Both of these latter risk fac-
tors are to a large extent determined by individual choice,
though both are also influenced by cultural and socio-eco-
nomic conditions. Active smoking and BMI therefore pro-
vide quantitative risk comparators for acute high dose
radiation exposure. However, there is no intention here to
make an ethical comparison between an imposed risk
(radiation exposure in an extreme event) and a (to an
extent) voluntary risk such as smoking or high BMI.
The comparison for extreme radiation risks in Table 3 may
be of limited value since such exposures are, fortunately,
rare. In addition, the comparison does not account for the
deterministic (i.e. ARS) effects of acute exposures in the
range 1–5 Gy which (by definition) does not influence the
YOLL of these A-bomb survivors. However, Table 3 does
put the health risks of active smoking and obesity into a
novel perspective.
Radiation risks
The risk estimates recommended by the International
Commission on Radiological Protection [15] are for
chronic exposures at relatively low dose rate rather than
the high dose rate exposures to the atomic bomb survi-
vors. In radiation risk assessments it is current practice to
assume that even very low dose radiation carries with it an
associated cancer risk (the linear, no-threshold or LNT
model). This assumption is based on radiobiological evi-
dence that DNA damage from a single radiation impact
can potentially lead to cancer. Although often inconclu-
sive at very low doses, epidemiological evidence also
tends to support the LNT model. A recent study [38] has
shown statistically significant excess cancer risk at acute
doses down to 60 mSv in the Japanese bomb survivors. In
a review [39] which included studies of medical and occu-
pational radiation exposures, it was argued that "good evi-
dence of an increase in risk for cancer is shown at acute
doses > 50 mSv, and reasonable evidence for an increase
in some cancer risks at doses above ≈ 5 mSv... good evi-
dence of an increase in some cancer risks is shown for pro-
tracted ["chronic"] doses > 100 mSv, and reasonable
evidence ... at protracted doses above ≈ 50 mSv".
Table 2: Approximate hypothetical lifetime increased mortality rate from illustrative scenarios of exposure to air pollution, passive 
smoking and radiationa.
Exposure scenario Exposure Health endpoint Approximate lifetime increased 
mortality
Living in Central London 
compared to Inverness.
Mix of air pollutants indicated by average 
PM2.5 = 6.9 μg m-3 higher.
Mortality 2.8 %
Postulated 2.8% higher air pollution related 
mortality in central London compared to 
Inverness (see text).
N.B. Extrapolates from data in the US. May be confounding factors which, if accounted for, would change the excess risk. Time-lag between 
exposure and effect is uncertain.
Passive smoking – risk to non-
smoker at home if spouse smokes.
Mix of pollutants in secondhand smoke. Mortality 1.7 %
1.7% lifetime excess IHD mortality risk 
from passive smoking: average for men and 
women [36].
N.B. Heart disease risk: does not include strokes or the (significantly lower) risk from lung cancer or other illnesses. May be confounding factors/
limitations of meta-analysis data.
Chernobyl emergency workers in 
the 30-km Zone 1986–87.
Radiation exposure:
100 mSv
250 mSv
Illustrative of mean (100 mSv) and high 
(250 mSv) doses: 4% of workers received 
doses >250 mSv.
Mortality
0.4 %
1.0 %
Predicted 4% risk of fatal cancer for 1000 
mSv dose to working age population.
N.B. Uncertainty in extrapolation from high dose and dose rate Japanese data to these chronic low doses. If the DDREF was not applied, mortality 
risk would increase by a factor of 2. Time lag between exposure and effect is generally long (> 10 years) for solid cancers, but is shorter (< 15 
years) for leukaemia. Note that 134 ARS victims received much higher doses than 250 mSv.
a. Note that health impacts change (generally, but not always, increase) with age. Risk also varies with age at time of exposure. For example, for air 
pollution, risks are believed to be higher for older people, but for radiation risks are higher from exposure at a young age (though effects may be 
observed after a long latency period). Risks may be distributed within the population in a different way for different risk factors. All risk factors have 
potential impacts on morbidity (illness) in addition to mortality.BMC Public Health 2007, 7:49 http://www.biomedcentral.com/1471-2458/7/49
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Exposure to low level radiation can potentially result in
hereditary effects on subsequent generations. Evidence of
effects on offspring has been observed in studies on labo-
ratory animals [40]. Studies on the children of the survi-
vors of the Hiroshima and Nagasaki bombs have,
however, found no evidence of hereditary effects of radia-
tion [41].
Lung cancer from exposures to radon and its decay prod-
ucts forms the major excess risk at high radon concentra-
tions in the home. The US National Academy of Sciences
[17] and US Environmental Protection Agency [18] have
recently re-assessed the lung cancer risk from exposures to
radon in the home. The stochastic mortality risk of 3.7%
at lifetime radon exposure of 750 mSv (Table 3, as calcu-
lated from [15]) will therefore be compared with these
more recent radon risk estimates.
The lifetime fatal lung cancer risk to an average member
of the US population at an average radon air concentra-
tion of 37 Bq m-3 is 0.58% assuming 70% of time is spent
at home [18]. At the UK action level for radon in the home
(200 Bq m-3), assuming LNT, this corresponds to a life-
time fatal lung cancer risk of 3.1%. This compares well
with the mortality risk estimate of 3.7% presented in
Table 1 for lifetime radon exposure at the UK action level,
though this does not necessarily imply that the ICRP and
EPA risk coefficients are the same: the former risk is calcu-
lated on the basis of an estimated effective radiation dose
whilst the latter relates risk directly to radon concentra-
tion in air from epidemiological studies of miners. In
addition, it should be noted that the more recent radon
risk estimates [17,18] show a much higher excess absolute
risk in smokers than in non-smokers due to the synergistic
effects of smoking and radon. The risk estimate presented
here is for an average population of smokers and non-
smokers (as is the case in the ICRP approach).
Air pollution risks – time series vs. cohort studies
It is well known that air pollution in cities can lead to sig-
nificant health problems. The London smog of 1952 was
reported to have caused an extra 4000 deaths in the capital
and a huge increase in hospital admissions for respiratory
and cardiovascular diseases. A pollution episode in
December 1991 was associated with an additional 101 to
178 deaths in London [42]. The impacts of air pollution
on health may be estimated by studies of short-term rela-
tionships between incidents and immediate health effects
("time-series studies") or by "cohort" studies relating
long-term air pollution to average morbidity (illness) and
mortality rates.
Time-series studies have identified clear relationships
between pollution episodes and mortality as exemplified
by the London incidents. There is uncertainty, however,
concerning assessment of the impact of such short-term
incidents, particularly in assessing the years of life lost
(YOLL) of the victims. Analyses of such incidents have
shown that they tend to bring forward the deaths of eld-
erly or seriously ill people (by a relatively small time
period) rather than immediately affecting generally
healthy people. A report of the Committee on the Medical
Effects of Air Pollutants [23] assumed that the loss of life
expectancy following short-term pollution episodes is on
average in the range 2–6 months, though it is possible that
deaths are brought forward by just a few days in many
cases.
Longer-term cohort studies, on the other hand, tend to
emphasise the long-term effects of chronic exposures. For
example, the U.S. "Six Cities Study" [43] followed the
health of a group of 8111 adults from 1974–1991. The
mortality rate in the most polluted of the six cities was
1.26 times higher than in the least polluted city (95% CI:
1.08–1.47). Deaths from lung cancer and cardiopulmo-
Table 3: Loss of life expectancy due to smoking, high body mass index and the long term effects of high acute radiation exposure.
Risk scenario Average Years of
Life Lost (YOLL)
Notes
Smoking
Male doctor who is a lifetime smoker compared to non-
smoker.
10 Ref. [6]. Average smoking habit: 18 a day from age 18.
Obesity
White male aged 35 who is obese (BMI = 30.0–39.9) or 
severely obese (BMI >40): risk relative to BMI = 24.
Obese:
1–4 a
Severely obese:
4–10a
Ref. [26]. There is controversy over the BMI-mortality 
relationship (see text). However, increased mortality at BMI > 
30 has been observed in a number of studies, though there is 
uncertainty in excess mortality rate and hence YOLL.
Radiation
Atomic bomb survivor who was in the most exposed 
group: within 1500 metres of the hypocentre. Shielded 
whole body kerma > 1 Gy, mean 2.25 Gy.
2.6
(1.3–5.2)a
Ref. [19]. Only represents YOLL of bomb survivors. Few people 
close to the hypocentre survived the combination of blast 
effects, burns and ARS.
a. Ranges are for different BMI or dose rates and are not uncertainty estimates.BMC Public Health 2007, 7:49 http://www.biomedcentral.com/1471-2458/7/49
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nary disease were correlated with levels of fine particulate
air pollution.
A discussion of the differences between cohort and time-
series studies of air pollution can be found in [44]. It has
been suggested [23] that reductions in air pollution would
lead to a "gain in life years from the cohort studies [which]
is at least 10-fold greater than estimates from the time-
series studies alone". Thus, cohort studies show a much
greater influence of air pollution on YOLL than time-
series studies. It has been noted [44] that "the total impact
(YOLL) of air pollution advancing deaths by a long time
... is estimable from cohort studies results". The meaning
of "a long time" in this context is not precisely defined,
but is likely to be greater than several months [44].
Whilst noting the many uncertainties and potential con-
founding factors in cohort studies, these can be used to
make tentative estimates of deaths brought forward by a
"long time" as a result of exposure to air pollution.
Uncertainties
All of the risk estimates discussed above are based on epi-
demiological studies and are therefore subject to statistical
uncertainties and potential confounding factors. Quoted
confidence intervals are limited in that they do not neces-
sarily encapsulate all possible sources of error in relative
risk estimates: it is rarely (if ever) possible to account for
all confounding factors. The limitations of epidemiologi-
cal studies are well known and results need to be treated
with great caution, particularly when observed relative
risks are low (less than, say, 2–3; [45]). Some of the risk
factors discussed here (acute exposure to > ~100 mSv radi-
ation, active smoking, very high BMI) are based on strong
epidemiological evidence and show clear dose-response
relationships, as illustrated in Figures 1, 2, 3. The other
risk factors (chronic low-dose radiation, passive smoking,
air pollution) are all subject to much greater uncertainty
and potential bias.
For statistical analyses of the various epidemiological
studies used, the reader is referred to the original refer-
ences on which the excess relative risks are based. It is not
always possible to present accurate objective confidence
intervals for these risk estimates. Where possible, confi-
dence intervals of relative risks are presented here, though
accurate confidence intervals were not always available
(for example, ref. [14] cites only a subjective CI). It is also
noted that quoted confidence intervals are limited in that
they do not necessarily encapsulate all possible sources of
error in relative risk estimates. Uncertainties in the various
risk factors are summarised in Table 4.
The risks arising from chronic, low-dose radiation are
determined to a large extent by linear extrapolation (LNT
model) from the data on Japanese atomic bomb survi-
vors, with a reduction due to predicted lower effectiveness
of low dose rate radiation in cancer induction (the
DDREF). There are ongoing arguments concerning the
shape of the dose-response curve at low doses and dose
rates with some arguing that risks may be significantly
higher or lower than predicted by the standard extrapola-
tion from high dose data.
There is also uncertainty in the risks of passive smoking
and air pollution. Both air pollution and passive smoking
studies may be compromised by socio-economic, envi-
ronmental or lifestyle factors which could not be
accounted for, even in large scale studies or meta-analyses
[46-48]. In addition, cohort studies of air pollution are
Table 4: Summary of available uncertainties in various risk factors.
Risk factor Uncertainty
Air pollution:
10 μg m-3 increase in PM2.5
RR of mortality is 1.04 with 95% CI: 1.01–1.08 [3] but note unexamined confounding 
factors could increase uncertainty.
Passive smoking:
Long-term exposure compared to little or no exposure.
RR of lung cancer [32] is 1.24 with 95% CI: 1.13–1.36
RR of heart disease [33] is 1.23 with 95% CI: 1.14–1.33
Excess mortality risk [36] was based only on heart disease RR of 1.31 and 1.24 for males 
and females respectively, at the higher end of the range given by [33].
Obesity:
High BMI compared to "normal" BMI = 24
Uncertainty in YOLL not presently available. Ref. [26] states that "we were unable to 
provide confidence intervals for our YLL estimates. We are unaware of any developed 
analytic formula that would allow easy calculation of SEs and confidence intervals". 
Uncertainties in relative risks are illustrated in Figure 2.
Radiation:
Risk per unit dose equivalent.
Subjective 95% CI was given for NAS risk analysis [14] where it was stated that 
"estimates that are a factor of two or three larger or smaller cannot be excluded" (see 
also [54]). This uncertainty is expected to also apply to the ICRP [15] risk estimates 
presented here. In particular, it is uncertain whether a DDREF should be applied: if a 
DDREF was not applied, this would increase the ICRP risk estimates by a factor of 2.BMC Public Health 2007, 7:49 http://www.biomedcentral.com/1471-2458/7/49
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necessarily based on health risks from past (generally
higher) exposures which may not apply today [46].
Conclusion
Whilst acknowledging the inevitable uncertainties in risk
assessment, the communication and mitigation of public
health risks must be based on the best available scientific
evidence. Nuclear incidents clearly have many serious
consequences, a full review of which is beyond the scope
of this paper. But the assessment of "best estimate" risk
scenarios presented here provides a context within which
to communicate the long-term mortality risk to those
exposed to radiation following such incidents. Such risk
communication could help to mitigate some of the seri-
ous social, economic and psychological impacts of inci-
dents involving radiation. When considered in the context
of other more common public health risk factors, the
long-term mortality risks from radiation exposures fol-
lowing major incidents, whilst very serious, appear to be
less serious than is commonly perceived. For example:
￿ The radiation exposures to the populations most
affected by the Chernobyl accident (emergency workers
and people continuing to live in contaminated areas)
results in an average additional mortality risk no greater
than that caused by (relatively common) elevated expo-
sures to natural background radiation either at home or
through occupation.
￿ The increased mortality rate of the populations most
affected by the Chernobyl accident may be comparable to
(and possibly lower than) risks from elevated exposure to
air pollution or environmental tobacco smoke. It is prob-
ably surprising to many (not least the affected popula-
tions themselves) that people still living unofficially in
the abandoned lands around Chernobyl may actually
have a lower health risk from radiation than they would
have if they were exposed to the air pollution health risk
in a large city such as nearby Kiev.
￿ The immediate effects of the Hiroshima and Nagasaki
atomic bombs led to approximately 210,000 deaths in the
two cities. However, radiation exposures experienced by
the most exposed group of survivors led to an average loss
of life expectancy significantly lower than that caused by
severe obesity or active smoking.
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